New York, NY, United States of America

Tg Therapeutics, Inc.


USPTO Granted Patents = 7

% Expired Patents = 42.9



Trademarks = 7

Forward Citations = 9

Loading Chart...
Loading Chart...

9 inventors (with patents filed for the assignee):

goldMedal Michael S Weiss (4 out of 4 patents)

silverMedal Peter Sportelli (4 out of 4 patents)

bronzeMedal George Costas Avgerinos (4 out of 4 patents)

4.  Patrick Michael Hossler (4 out of 4 patents)

5.  Yune Z Kunes (4 out of 4 patents)

6.  Jill A Myers (4 out of 4 patents)

7.  Hari P Miskin (3 out of 3 patents)

8.  Swaroop K V S Vakkalanka (2 out of 6 patents)

9.  Sri Hari Pandurang Miskin (1 out of 1 patent)

10.  Michael Joseph Weiss (22 patents)

11.  Hari Miskin (0 patent)

12.  Swaroop Kvs Vakkalanka (0 patent)

13.  Hari Miskin (0 patent)

14.  Swaroop KVS Vakkalanka (0 patent)


7 patents:

TG Therapeutics is a biopharmaceutical company focused on the development and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Their pipeline includes innovative therapies targeting various diseases, including lymphoma and multiple sclerosis. With a strong commitment to advancing patient care, TG Therapeutics continues to drive research and development efforts to bring new treatment options to those in need.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

7 Patents

#902 in New York, NY

#2,358 in New York

#39,856 in US

New York, NY (US)
New York, NY, United States of America
Forward Citations = 9

9 inventors:

Please report any incorrect information to [email protected]
Loading…